Cover Image

SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Yuan, Shijie, Liu, Jiaxin, Gong, Zhihua, Qin, Xia, Qin, Crystal, Ji, Yuan, Müller, Peter
Format:	Preprint
Published:	2025
Subjects:	Applications Methodology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Monitoring Adverse Events Through Bayesian Nonparametric Clustering Across Studies
by: Yuan, Shijie, et al.
Published: (2025)

MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials
by: Lyu, Jiaying, et al.
Published: (2020)

Mixture of Finite Mixtures Model for Basket Trial
by: Geng, Junxian, et al.
Published: (2020)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
by: Yang, Peng, et al.
Published: (2026)

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
by: Pramanik, Paramahansa, et al.
Published: (2026)

A Clustering Approach for Basket Trials Based on Treatment Response Trajectories
by: Kojima, Masahiro, et al.
Published: (2025)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)

Robust Power and Sample Size Calculations in Quasi-likelihood Models: Methods and Practice
by: Yuan, Shijie, et al.
Published: (2026)

Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
by: Wang, Sidi, et al.
Published: (2026)

Bayesian Hierarchical Modeling for Bivariate Multiscale Spatial Data with Application to Blood Test Monitoring
by: Zhou, Shijie, et al.
Published: (2023)

Priors from Envisioned Posterior Judgments: A Novel Elicitation Approach With Application to Bayesian Clinical Trials
by: Ouyang, Yongdong, et al.
Published: (2024)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)

A Bayesian Framework for Latent Compliance Modeling in Cluster Randomized Trials with One-Sided Noncompliance
by: Sisti, Anthony, et al.
Published: (2025)

Scalable Decisions using a Bayesian Decision-Theoretic Approach
by: Ng, Hoiyi, et al.
Published: (2026)

Modeling Time-Varying Effects of Mobile Health Interventions Using Longitudinal Functional Data from HeartSteps Micro-Randomized Trial
by: Yu, Jiaxin, et al.
Published: (2024)

Bayesian Design and Analysis of Precision Trials with Partial Borrowing
by: Golchi, Shirin, et al.
Published: (2026)

Bayesian Spatial Point Process Modeling for Cluster Randomized Trials
by: Lee, Jooyeon, et al.
Published: (2025)

Multiscale Multi-Type Spatial Bayesian Analysis for High-Dimensional Data with Application to Wildfires and Migration
by: Zhou, Shijie, et al.
Published: (2024)

Confirmatory Biomarker Identification with k-FWER Control Using Derandomized Knockoffs with Cox Regression
by: Liu, Rui, et al.
Published: (2025)

Is Repeated Bayesian Interim Analysis Consequence-Free?
by: Liu, Suyu, et al.
Published: (2025)

Subgroup comparisons within and across studies in meta-analysis
by: Panaro, Renato, et al.
Published: (2025)

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
by: Phillips, Rachael V., et al.
Published: (2024)

A Bayesian Approach to Modeling Variance of Intensive Longitudinal Biomarker Data as a Predictor of Health Outcomes
by: Yu, Mingyan, et al.
Published: (2024)

Bayesian Inference for Joint Tail Risk in Paired Biomarkers via Archimedean Copulas with Restricted Jeffreys Priors
by: Aich, Agnideep, et al.
Published: (2026)

Borrowing strength between unaligned binary time-series via Bayesian nonparametric rescaling of Unified Skewed Normal priors
by: Cantoni, Beatrice, et al.
Published: (2025)

Heterogeneous Clinical Trial Outcomes via Multi-Output Gaussian Processes
by: Thomas, Owen, et al.
Published: (2024)

E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
by: Sokolova, Alexandra, et al.
Published: (2026)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
by: Maity, Arnab Kumar, et al.
Published: (2024)

Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
by: Long, James P., et al.
Published: (2025)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
by: Lotspeich, Sarah C., et al.
Published: (2026)

Identifying Treatment Effect Heterogeneity with Bayesian Hierarchical Adjustable Random Partition in Adaptive Enrichment Trials
by: Zhao, Xianglin, et al.
Published: (2025)

Bayesian Fractional Polynomials for Optimal Dosage Estimation with Fish Nutrition Applications
by: Hubin, Aliaksandr, et al.
Published: (2026)

Estimating Interpretable Heterogeneous Treatment Effect with Causal Subgroup Discovery in Survival Outcomes
by: Bo, Na, et al.
Published: (2024)

Eligibility-Aware Evidence Synthesis: An Agentic Framework for Clinical Trial Meta-Analysis
by: Zhao, Yao, et al.
Published: (2026)

Pharmacometrics-Enabled DOse OPtimization (PEDOOP) for Seamless Phase I-II Trials in Oncology
by: Yuan, Shijie, et al.
Published: (2023)

A Bayesian Framework for Multivariate Differential Analysis
by: Chion, Marie, et al.
Published: (2023)

Statistical Performance Guarantee for Subgroup Identification with Generic Machine Learning
by: Li, Michael Lingzhi, et al.
Published: (2023)

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
by: Zhang, Cong, et al.
Published: (2026)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)